Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza
Status:
Unknown status
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
A Pilot Study to Evaluate the Safety and Efficacy of interferon-Alfacon1 (INFERGEN) in the
treatment of patients hospitalized with Influenza-like illness caused by a novel swine origin
Influenza virus and other circulating Influenza Viruses.
The use of Interferon-alfacon1 as a co-treatment along with the standard of care antiviral is
hypothesized to be safe. Clinical improvement of patients is hypothesized to be quicker.